title: Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.
abstract: OBJECTIVE
  The objective of this study was to characterize the patient population with respect to patient selection, assess surgical morbidity and graft failures, and analyze the contribution of perioperative clinical factors to recipient outcome in adult living donor liver transplantation (ALDLT).
  
  
  BACKGROUND
  Previous reports have been center-specific or from large databases lacking detailed variables. The Adult-to-Adult Living Donor Liver Transplantation Cohort Study (A2ALL) represents the first detailed North American multicenter report of recipient risk and outcome aiming to characterize variables predictive of graft failure.
  
  
  METHODS
  Three hundred eighty-five ALDLT recipients transplanted at 9 centers were studied with analysis of over 35 donor, recipient, intraoperative, and postoperative variables. Cox regression models were used to examine the relationship of variables to the risk of graft failure.
  
  
  RESULTS
  Ninety-day and 1-year graft survival were 87% and 81%, respectively. Fifty-one (13.2%) grafts failed in the first 90 days. The most common causes of graft failure were vascular thrombosis, primary nonfunction, and sepsis. Biliary complications were common (30% early, 11% late). Older recipient age and length of cold ischemia were significant predictors of graft failure. Center experience greater than 20 ALDLT was associated with a significantly lower risk of graft failure. Recipient Model for End-stage Liver Disease score and graft size were not significant predictors.
  
  
  CONCLUSIONS
  This multicenter A2ALL experience provides evidence that ALDLT is a viable option for liver replacement. Older recipient age and prolonged cold ischemia time increase the risk of graft failure. Outcomes improve with increasing center experience.
authors.affiliation: Department of Surgery, University of Pennsylvania, Philadelphia, PA 19104, USA. kim.olthoff@uphs.upenn.edu
authors.forename: Kim M
authors.initials: KM
authors.lastname: Olthoff
authors.forename: Robert M
authors.initials: RM
authors.lastname: Merion
authors.forename: Rafik M
authors.initials: RM
authors.lastname: Ghobrial
authors.forename: Michael M
authors.initials: MM
authors.lastname: Abecassis
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Fair
authors.forename: Robert A
authors.initials: RA
authors.lastname: Fisher
authors.forename: Chris E
authors.initials: CE
authors.lastname: Freise
authors.forename: Igal
authors.initials: I
authors.lastname: Kam
authors.forename: Timothy L
authors.initials: TL
authors.lastname: Pruett
authors.forename: James E
authors.initials: JE
authors.lastname: Everhart
authors.forename: Tempie E
authors.initials: TE
authors.lastname: Hulbert-Shearon
authors.forename: Brenda W
authors.initials: BW
authors.lastname: Gillespie
authors.forename: Jean C
authors.initials: JC
authors.lastname: Emond
mesh_terms: D000328:Adult; D000367:Age Factors; D015331:Cohort Studies; D005260:Female; D006085:Graft Survival; D006801:Humans; D017093:Liver Failure / Q000601:surgery; D016031:Liver Transplantation / Q000706:statistics & numerical data*; D019520:Living Donors; D008297:Male; D008875:Middle Aged; D009656:North America / Q000453:epidemiology; D018579:Patient Selection; D011183:Postoperative Complications; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome